HOME › DRUGS › PONESIMOD
ACTIVE SUBSTANCE / INN

PONESIMOD

Brand name(s): PONVORY, Ponvory
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA213498
Multiple Sclerosis, Relapsing-Remitting
ACTIVE SUBSTANCE
Ponesimod
REGULATORS
FDA · EMA
SPONSORS / MAH
Laboratoires Juvisé Pharmaceuticals, VANDA PHARMS INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PONVORYNDA213498VANDA PHARMS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PonvoryLaboratoires Juvisé PharmaceuticalsAuthorised19/05/2021Multiple Sclerosis, Relapsing-Remitting

FULL INTELLIGENCE ON PONESIMOD

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →